N-(6-chloro-1,3-benzothiazol-2-yl)-2-[(3S,4S)-4-(3-fluorophenoxy)-3-hydroxy-3-methylpiperidin-1-yl]acetamide
C21H21ClFN3O3S — CID 110162519
Data last refreshed: (MolForge compound catalog, from PubChem)
About N-(6-chloro-1,3-benzothiazol-2-yl)-2-[(3S,4S)-4-(3-fluorophenoxy)-3-hydroxy-3-methylpiperidin-1-yl]acetamide
N-(6-chloro-1,3-benzothiazol-2-yl)-2-[(3S,4S)-4-(3-fluorophenoxy)-3-hydroxy-3-methylpiperidin-1-yl]acetamide (PubChem CID 110162519) has the molecular formula C21H21ClFN3O3S and a molecular weight of 449.94 g/mol. Its IUPAC name is N-(6-chloro-1,3-benzothiazol-2-yl)-2-[(3S,4S)-4-(3-fluorophenoxy)-3-hydroxy-3-methylpiperidin-1-yl]acetamide.
Molecular Properties
| Compound Name | N-(6-chloro-1,3-benzothiazol-2-yl)-2-[(3S,4S)-4-(3-fluorophenoxy)-3-hydroxy-3-methylpiperidin-1-yl]acetamide |
|---|---|
| PubChem CID | 110162519 |
| Molecular Formula | C21H21ClFN3O3S |
| Molecular Weight | 449.94 g/mol |
| Exact Mass | 449.10 |
| IUPAC Name | N-(6-chloro-1,3-benzothiazol-2-yl)-2-[(3S,4S)-4-(3-fluorophenoxy)-3-hydroxy-3-methylpiperidin-1-yl]acetamide |
| SMILES | C[C@]1(O)CN(CC(=O)Nc2nc3ccc(Cl)cc3s2)CC[C@@H]1Oc1cccc(F)c1 |
| InChI | InChI=1S/C21H21ClFN3O3S/c1-21(28)12-26(8-7-18(21)29-15-4-2-3-14(23)10-15)11-19(27)25-20-24-16-6-5-13(22)9-17(16)30-20/h2-6,9-10,18,28H,7-8,11-12H2,1H3,(H,24,25,27)/t18-,21-/m0/s1 |
| InChIKey | FAHVWOALGKQWCD-RXVVDRJESA-N |
| XLogP | 3.93 |
| TPSA | 74.69 Ų |
| H-Bond Donors | 2 |
| H-Bond Acceptors | 6 |
| Rotatable Bonds | 5 |
| Heavy Atoms | 30 |
| Complexity | — |
Lipinski Rule of Five
Passes Rule of Five
| Rule | Value |
|---|---|
| MW ≤ 500 | 449.94 |
| LogP ≤ 5 | 3.93 |
| H-Bond Donors ≤ 5 | 2 |
| H-Bond Acceptors ≤ 10 | 6 |
Frequently Asked Questions
Browse: Molecules A–Z · all molecules A–Z · drugs A–Z · protein targets A–Z.
Sources
- PubChem CID 110162519 — identifiers, structure, computed properties (public domain)
How this page is built: methodology · editorial policy & corrections.
For research and educational use only — not medical advice. This page is compiled automatically from public databases. It is not written or reviewed by a clinician. Do not start, stop or change any treatment based on it; consult a qualified healthcare professional. Spotted an error? See our corrections policy or email hello@molforge.ai.